Brendan Farnand
Physician Assistant · Buffalo, NYNPI 1245739333
Payments from drug & device makers
Across 240 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Insulet Corporation$468
- GSK$431
- AstraZeneca$376
- Lilly USA, LLC$246
- Exact Sciences$180
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,679100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $1,069 |
| Insulet Corporation | 22 | $468 |
| GSK | 24 | $431 |
| AstraZeneca | 20 | $376 |
| Lilly USA, LLC | 20 | $246 |
| Exact Sciences | 7 | $180 |
| Novo Nordisk | 11 | $171 |
| Biohaven Pharmaceuticals, Inc. | 5 | $162 |
| Amgen | 3 | $162 |
| Pfizer | 9 | $161 |
| Sanofi-aventis U.S. LLC | 3 | $159 |
| Abbott | 6 | $155 |
| Gilead | 5 | $109 |
| Boehringer Ingelheim | 5 | $83 |
| Philips North America LLC | 5 | $69 |
| Eisai Inc. | 5 | $69 |
| Irhythm Technologies, Inc. | 2 | $64 |
| Mannkind Corporation | 3 | $54 |
| Viiv Healthcare Company | 2 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Scilex Pharmaceuticals Inc. | 3 | $50 |
| Almatica Pharma LLC | 3 | $44 |
| Johnson & Johnson | 2 | $42 |
| Dexcom, Inc. | 3 | $39 |
| Mylan Specialty L.p. | 2 | $33 |
| Grifols USA, LLC | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $27 |
| Impel Pharmaceuticals Inc. | 1 | $22 |
| Novartis | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Bayer | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$125
- TOUJEO$124
- FreeStyle Libre Pro$115
- TRELEGY ELLIPTA$112
- NURTEC ODT$111
- LINZESS$106
How this compares
$4,679 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 58 | $79,285 |
| JanuviaSitagliptin Phosphate | 63 | $72,054 |
| JardianceEmpagliflozin | 34 | $46,936 |
| EliquisApixaban | 48 | $38,857 |
| JanumetSitagliptin Phos/Metformin Hcl | 26 | $27,604 |
| TradjentaLinagliptin | 29 | $24,574 |
| TrulicityDulaglutide | 17 | $19,218 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 18 | $18,182 |
| ProliaDenosumab | 11 | $17,923 |
| LinzessLinaclotide | 25 | $17,677 |
| MounjaroTirzepatide | 13 | $15,056 |
| XareltoRivaroxaban | 15 | $14,045 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 29 | $12,714 |
| VascepaIcosapent Ethyl | 15 | $12,326 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 140 | $6,037 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $171 | $79,28558 claims |
| Boehringer IngelheimJardiance, Tradjenta | $83 | $71,51163 claims |
| PfizerEliquis | $161 | $38,85748 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $246 | $34,27430 claims |
| AmgenProlia | $162 | $17,92311 claims |
| AbbVieLinzess | $1,069 | $17,67725 claims |
| Johnson & JohnsonXarelto | $42 | $14,04515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Buffalo
- Scott SpringerBuffalo$95K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.